Mycoses

Article	Citations
Author Index	58
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	39
	38
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	37
Issue Information	33
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	32
T Cell Exhaustion and Function State Correlated With Outcomes in Patients With Intra‐Abdominal Candidiasis	30
Issue Information	28
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	27
Review Article White Piedra: Review of 131 cases	26
Physicians' knowledge of invasive fungal disease in China	25
Aspergillosis and Mucormycosis‐Associated Hospitalizations, United States, 2016–2021	24
Issue Information	24
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	24
The Importance of Early Mycological Clearance of Uncomplicated Candidaemia and Its Implications for Clinical Practice	23
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	22
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	21
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	21
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	20
Issue Information	20
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	20
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	20
Cover Image	19
Issue Information	19
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	19

Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	19
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance	18
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	18
Utility and Pitfalls of β‐D‐Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients	18
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	18
	18
Issue Information	18
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	18
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	17
Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review	17
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	17
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	16
Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis	16
Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.	15
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	15
Optimisation of a Murine Infection Model With Trichophyton mentagrophytes for Studying the Pathogenesis of Dermatophytosis	15
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	15
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	15
Unravelling Voriconazole's Hepatic Metabolism: A Narrative Review on Factors Impacting Voriconazole‐N‐Oxide Exposure	15
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	14
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	14
Rapid Detection of Fungi in Nail Specimens Using Multi‐Tube Recombinase Polymerase Amplification Assay	14
	14
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	14
Tinea pedis in underrepresented groups: All of Us database analysis	14
Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Tri	14
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	14
Dermoscopic Features of Tinea Capitis in Korean Patients: Correlation With Clinical Subtypes, Age Groups and Causative Dermatophytes	13
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	13
	13
Diagnostic performance of noncultural methods for central nervous system aspergillosis	13
	13
	13
Epidemiology and Pathogen Shift of Tinea Capitis: A Comparative Analysis of Adults and Children in Nanchang, China (2022–2024)	13
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	13
Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis	13
Neglected Mycoses in Brazil: A Population‐Based Study of Mortality and In‐Hospital Mortality Over 25 Years	13
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	13
The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment	13
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	13
CARD9 mutations in patients with fungal infections: An update from the last 5 years	13
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	12
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	12
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	12
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	12
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	12
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	12
Zoonotic and Anthropophilic Trichophyton mentagrophytes Complex Infection in Human: An Update and Narrative Review	12
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	11
	11

Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	11
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	11
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	11
	11
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	11
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	11
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	11
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	11
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	11
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	11
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	11
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	11
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	11
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	11
Biologic Therapy and Superficial Fungal Infection Risk in Moderate‐to‐Severe Psoriasis: A Meta‐Analysis	10
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	10
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	10
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	10
Epidemiology of Triazole Resistant Aspergillus fumigatus in Asia: A Systematic Review and Meta‐Analysis	10
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	10
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	10
	10
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	9
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	9
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	9
	9
Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study	9
Characterisation of Antifungal Prophylaxis and Therapy Among Inpatients With Haematological Malignancies in Non‐Research Clinical Setting: A Multicentre Italian Experience	9
Coccidioidomycosis in Oklahoma: A retrospective case series	9
Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts	9
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	9
Issue Information	9
Infrared Spectroscopy as a Promising Tool for Diagnosing and Typing Human Pathogenic Fungi	9
Biocide Response of Candida auris	9
Global Emergence of Antifungal‐Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytesITS Genotype VIII): A Genomic Investigation In	9
Updated estimation of the burden of fungal disease in Vietnam	9
Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related	9
Aspergillus nodules: Natural history and the effect of antifungals	9
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species‐Specific IgG	9
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	9
Issue Information	9
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	9
	9
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	9
The First Isolation of Multiple Antifungal‐Drug‐Resistant Trichophyton Rubrum in China and the Novel Resistance Mechanism	8
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	8
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	8
Time and cost‐efficient identification of Trichophyton indotineae	8
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	8
Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China	8
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	8
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	8
Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production	8
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	8
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	8
Abstracts	8
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	8
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	8
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	8
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	8
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	8
Issue Information	8
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	8
Issue Information	8
Diagnostic Performance of Sōna GM LFA in Pulmonary Infections Caused by Different Aspergillus Species	8
	8
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	8
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	8
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	8
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	7
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	7
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	7
	7
Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China	7
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	7
	7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	7
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	7
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	7
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	7

Airway Mycobiota—Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study	7
Issue Information	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany	7
	7
Altered skin fungal and bacterial community compositions in tinea capitis	7
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital	7
	7